Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Total 13F shares
-
26,299,986
-
Share change
-
+1,509,925
-
Total reported value
-
$965,984,248
-
Put/Call ratio
-
3.6%
-
Price per share
-
$36.73
-
Number of holders
-
96
-
Value change
-
+$58,612,650
-
Number of buys
-
40
-
Number of sells
-
53
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q4 2021
As of 31 Dec 2021,
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,299,986 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, FMR LLC, BlackRock Inc., Ponoi Management, LLC, Column Group LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, VANGUARD GROUP INC, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.